PennyStock Buzz: Don’t Forget. AXXE is my new alert. One of the biggest revenue performances. Open now!

Recommended Stock Newsletters
 
#1. PennyStockWarfare
#2. Nova Stocks
#3. Penny Stock Finder

PennyStock Buzz Newsletter

AXXE Seduces Traders With Exceptional 2014 – Increases Inventory to $1 Million Good Morning! Few companies can boast the sort of year-end credentials of AXXE, especially as it relates to the strengthening of partnerships and sales outlook. The company was on fire all of 2014.

Just yesterday AXXE reminded Wall Street of why it’s the best trade idea in the pain relief and muscle supplements space. The company confirmed that over the course of 2014 it strengthened its inventory to the tune of $1 million and signed major distribution deals with some of the biggest retailers across the country.

Several other details were highlighted but of particular interest to me was news that AXXE still intends to continue supplying the Army Air force Exchange Service (AAFES) with its TapouT branded line of muscle supplements. Over the course of 2014 AXXE made several big fulfillments to the AAFES and if those orders are increased again this year, I expect the revenue haul to be very strong.

Of course I can’t forget the strong online distribution channels setup over the course of last year. This includes the biggest commercial fish of all – Amazon.com.

With such strong fundamentals to start the year you have to wonder of the technicals can be any better, right Well, technically you can’t find a better play to pounce on – certainly not in the extremely popular muscle supplements sector. AXXE has it all.

Up 30% since the start of December, AXXE has seen consolidation below .20.

Relative strength levels just tease upside potential and traders looking for a high-liquidity trade really can’t do better.

AXXE is a very good entry at current levels so make sure your due diligence is pristine on it – ASAP.

Investor Highlights AXXE had one of its biggest revenue performances ever, thanks in large part to the year-round supply of muscle supplements to the Army Air force Exchange Service (AAFES) AXXE said in a recent update that it intends to strengthen its relationship with the AAFES in 2015. According to the update the AAFES had worldwide sales of $9.2 billion last year.

AXXE’s product line was boosted in 2014 with the addition of a TapouT Turbo Blend Protein Powder. The company says it intends to launch an Omega-3 fish oil product in 2015.

AXXE has traded well over the course of 2014 and its 12-month high is .50.

Present valuation is 233% below this high which means AXXE has very strong upside potential AXXE has a RSI of 44. Pullbacks have largely led to the current oversold levels but the reversal opportunity is now very strong.

Liquidity levels are strong and AXXE has average volume of 219K. There’s also some accumulation on the MACD which suggests that a strong breakout could be building.

AXXE is trading just 9% below its 50 DMA. With current momentum being as strong as it is, the window to catch the breakout is small so traders must act fast.

About AXXE AXXE (Axxess Pharma Inc.), a pharmaceutical company, engages in the marketing and distribution of various pharmaceutical products and diagnostic medical devices in Canada and internationally.

AXXE distributes dermatological, therapeutic nutritional, pain management, and diagnostic products.

AXXE’s is a licensee for the TapouT brand and the company has been distributing its own Tapout-branded line of muscle supplements and pain relief supplements.

AXXE distributes its products through physicians, hospitals, government and defense institutions, and pharmacies. The company was founded in 1997 and is headquartered in Markham, Canada.

Sports Nutrition to Hit $91.18 Billion Due to a growing global awareness of the importance of exercise to overall health coupled with the increasing acceptance of the nutraceutical market, consumer demand for supplements geared towards sports nutrition will continue to see strong sales. Many supplement manufacturers have expanded offerings for distributors based on increased sales within this segment.

According to BCC Research, the global market for sports nutrition products is expected to have a compound annual growth rate of 24.1%, and projected to reach $91.18 billion this year.

One reason for explosive growth of sports performance supplements is a changing product market focus. Traditionally, sports endurance supplements were heavily geared towards body-building and professional athletes.

Recent Developments Axxess Pharma Provides 2014 Year End Update Management Preparing to Enter Big Box Retail Chain Stores, Across United States Within 6 Months TORONTO, ON–(Marketwired – Jan 5, 2015) – Axxess Pharma Inc. (OTC PINK:

AXXE) a specialty pharmaceutical and nutritional supplements company, is pleased to announce, through its wholly-owned subsidiary, AllStar Health Brands Inc., their 2014 Year-End update.

2014 was a strong year for AllStar Health Brands as they expanded their line of all-natural TapouT products, entered their product line into leading online retail stores and retained Acosta, a leading sales and marketing firm serving the markets top consumer goods retail companies such as Kellog`s, Cambell`s and The Clorox Company.

Acosta will be working with AllStar Health Brands to enter their highly recognized TapouT brand into thousands of big box retail chains across the United States. In addition to these accomplishments, AllStar has achieved many other goals, paving the way for global product sales in 2015.

In 2014 AllStar Health Brands:

* Signed major promotional deal with ROC Nation. Under the agreement AllStar Health Brands partnered Roc Nation Sports on their first three boxing events under the throne boxing banner. The first event will be scheduled at none other than Madison Square Garden on Jan 9. Axxess Pharma and Roc Nation Sports will work together to promote the TapouT Muscle product line and throne boxing events.

* 2014 began sales, and received first order with the US Military (Army Air force Exchange Service- AAFES) Based on AllStar Health Brands successful order fulfillments with AAFES throughout 2014, AAFES is now in discussions with the company to expand their distribution of AllStars TapouT Line. AAFES has 130 bases in the US and world-wide. However, world-wide there are 2,817 facilities in 30 countries-all fifty states and five US territories. World-wide retail sales from AAFES facilities, last year reached $9.2 Billion.

* Began online sales through Amazon.com, RonnieColemannutrition.com, Go4itNutrition.com, and TapouTMuscle Recovery.com and several other sites.

* Added new products including a 2 lb. TapouT Turbo Blend Protein Powder, a high demand Omega-3 fish oil and soon to be launched: a line of Ready to Drink protein meal replacement products, and an all-natural testosterone booster.

* Expected to be in thousands of big box retail chain stores by middle of 2015. Protein powder and Ready-To-Drink (RTD`s) protein meal replacement products anticipated to be the first of the all-natural TapouT line on the big box shelves.

* Protein Meal Replacement Ready-To-Drink (RTDs), expected to be biggest driver of sales growth for 2015.

* Received Canadian approval for several products including the unique, high potency, premium grade Omega-3 fish oil supplement. The source for the premium Omega-3 Fish Oil is Chilean and Peruvian open-ocean sourced anchovy, sardine and mackerel. This ensures no antibiotics or other additives are part of their diet. Canada`s yearly fish oil sales within the country exceeds $1 billion. AllStar Health Brands anticipates strong sales growth in Canada fueled by aggressive marketing and their globally recognized TapouT name.

* Opened strong international distribution channels with HardCore Beverages of Australia. Distribution to include several countries such as Australia, New Zealand, South Korea and Indonesia.

* Built up inventory levels of approximately $1 million. Management increased inventory in order to meet the anticipated rise in demand due to the recent agreements additional retailers.

Dr. Daniel Bagi, President of Axxess Pharma, stated, “This has been a very busy and successful year, as we have entered our all-natural TapouT product line into several markets, strengthened our relationship and sales with the US Military (AAFES), retained Acosta, the leading outsourced sales and marketing agency firm serving consumer packaged goods companies and retailers across the United States and Canada.

Acosta will be our major driving force in placing our highly recognized TapouT line into thousands of major big box retail stores across the United States. We have also retained celebrity sponsors and recently partnered with the high profile promotion company Roc Nation.” Dr. Bagi further stated, “Overall, we have barely scratched the surface of where we believe our sales can go in the US and overseas. This is really just the beginning for us. Axxess Pharma believes the launch of our latest products, will add significantly to our revenue growth in 2015.” Start your research on AXXE ASAP.

To learn more about AXXE please visit their website:

[1]http://www.axxesspharmainc.com/

Regards, PennyStock Buzz We answer all email DISCLAIMER This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated and edited by Stellar Media Group, LLC. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” or “Stellar Media” refers to Stellar Media Group, LLC. Our business model is to be financially compensated to market and promote small public companies. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research.

Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website.

We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data.

This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here.

Stellar Media’s business model is to receive financial compensation to promote public companies. We have been compensated Twenty five thousand dollars cash via bank wire by a third party, The Stocks Alerts, LLC, to conduct investor relations advertising and marketing for AXXE. This compensation is a major conflict of interest in our ability to be unbiased regarding . Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forword looking statements, which are not guaranteed to materialize due to a variety of factors.

We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct.

The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct.

Furthermore, Stellar Media often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice. See full disclaimer at [2]http://penny-stock-buzz.com/disclaimer.

References 1. http://www.axxesspharmainc.com/

2. http://penny-stock-buzz.com/disclaimer
This message was sent to from:

PennyStock Buzz | info@penny-stock-buzz.com | DamnGoodPennyPicks | 905 W. 35th Street | Chicago, IL 60609

 
This entry was posted in Stock Newsletters and tagged , . Bookmark the permalink.

Comments are closed.